Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023)
Tyra Biosciences' (TYRA) quarterly Other Non Operating Income came in at -$5000.0 in Q3 2023, down 200.0% YoY from $5000.0 in Q3 2022, and down 200.0% on a QoQ basis from $5000.0 in Q3 2022.
Powered by 
Analysis
Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023) Analysis & Trends
Tyra Biosciences (TYRA) has 2 years of Other Non Operating Income data on file, last reported at -$5000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Tyra Biosciences | 1.88 Bn | 1.88 Bn | - |